Status:
RECRUITING
Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication
Lead Sponsor:
British University In Egypt
Conditions:
Endodontic Disease
Pulp Disease, Dental
Eligibility:
All Genders
21-49 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of the study is to evaluate the anti-bacterial potential of Nano Calcium Hydroxide as an intracanal medication in primary endodontic treatment of permanent molars.
Detailed Description
This study is conducted to evaluate the bacterial reduction capability of hydrogel loaded with Nano Calcium Hydroxide and paste form of nano and conventional calcium hydroxide as an intracanal medicat...
Eligibility Criteria
Inclusion
- healthy males and females.
- age range between 21-49.
- patients with no physical disability or psychological problems.
- patients presenting with single permanent molar with signs and/or symptoms of apical periodontitis, and having Periapican index ≥ 2.
Exclusion
- pregnant women.
- patients with immune-compromised disease.
- patients with complicated systemic diseases.
- patients who took antibiotics within a period of 1 month.
- patients with known sensitivity to the medicaments or pharmaceuticals used in this study.
- Non-restorable teeth including root fractures, and/or advanced periodontal involvement.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06196515
Start Date
August 1 2024
End Date
December 1 2025
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
british university in Egypt - dentistry collage
Cairo, Egypt